Cha SS - Search Results

1

Sample size and design considerations for phase II clinical trials with correlated observations.

Sargent DJ, Sloan JA, Cha SS. Sargent DJ, et al. Among authors: cha ss. Control Clin Trials. 1999 Jun;20(3):242-52. doi: 10.1016/s0197-2456(98)00058-0. Control Clin Trials. 1999. PMID: 10357497

2

Phase II study of paclitaxel and cisplatin for advanced urothelial cancer.

Burch PA, Richardson RL, Cha SS, Sargent DJ, Pitot HC 4th, Kaur JS, Camoriano JK. Burch PA, et al. Among authors: cha ss. J Urol. 2000 Nov;164(5):1538-42. J Urol. 2000. PMID: 11025699 Clinical Trial.

3

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

Alberts SR, Townley PM, Goldberg RM, Cha SS, Sargent DJ, Moore DF, Krook JE, Pitot HC, Fitch TR, Wiesenfeld M, Mailliard JA. Alberts SR, et al. Among authors: cha ss. Ann Oncol. 2003 Apr;14(4):580-5. doi: 10.1093/annonc/mdg170. Ann Oncol. 2003. PMID: 12649105 Free article. Clinical Trial.

4

Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer.

Sloan JA, Goldberg RM, Sargent DJ, Vargas-Chanes D, Nair S, Cha SS, Novotny PJ, Poon MA, O'Connell MJ, Loprinzi CL. Sloan JA, et al. Among authors: cha ss. J Clin Oncol. 2002 Mar 15;20(6):1491-8. doi: 10.1200/JCO.2002.20.6.1491. J Clin Oncol. 2002. PMID: 11896096

5

Intraoperative radiotherapy for head and neck and skull base cancer.

Pinheiro AD, Foote RL, McCaffrey TV, Kasperbauer JL, Bonner JA, Olsen KD, Cha SS, Sargent DJ. Pinheiro AD, et al. Among authors: cha ss. Head Neck. 2003 Mar;25(3):217-25; discussion 225-6. doi: 10.1002/hed.10203. Head Neck. 2003. PMID: 12599289 Clinical Trial.

6

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM. Gill S, et al. Among authors: cha ss. J Clin Oncol. 2004 May 15;22(10):1797-806. doi: 10.1200/JCO.2004.09.059. Epub 2004 Apr 5. J Clin Oncol. 2004. PMID: 15067028

7

Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.

Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Giuntoli RL 2nd, et al. Among authors: cha ss. Gynecol Oncol. 2003 Jun;89(3):460-9. doi: 10.1016/s0090-8258(03)00137-9. Gynecol Oncol. 2003. PMID: 12798712

8

Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study.

Alberts SR, Townley PM, Goldberg RM, Cha SS, Moore DF Jr, Krook JE, Pitot HC, Fitch TR, Wiesenfeld M, Mailliard JA, Sargent DJ. Alberts SR, et al. Among authors: cha ss. Ann Oncol. 2002 Apr;13(4):553-7. doi: 10.1093/annonc/mdf062. Ann Oncol. 2002. PMID: 12056705 Free article. Clinical Trial.

9

Curative potential of multimodality therapy for locally recurrent rectal cancer.

Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O'Connell MJ, Cha S, Sargent DJ, Horgan A. Hahnloser D, et al. Ann Surg. 2003 Apr;237(4):502-8. doi: 10.1097/01.SLA.0000059972.90598.5F. Ann Surg. 2003. PMID: 12677146 Free PMC article.

10

TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk.

Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL 2nd, McGovern RM, Sloan JA, Cha SS, Persing DH. Gostout BS, et al. Among authors: cha ss. Gynecol Oncol. 2003 Mar;88(3):326-32. doi: 10.1016/s0090-8258(02)00074-4. Gynecol Oncol. 2003. PMID: 12648582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

397 results

Search Page